GWAS

Diverse genetic and environmental factors such as stress or UV exposure can spark autoimmune diseases. 

Researchers identified schizophrenia risk genes that mediate placental, rather than brain, function, revealing new insight into the disease’s developmental origins.

Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.

Researchers use GWAS to understand why some people lose their sense of smell and taste when they are infected with COVID-19.

Researchers combined genome, phenotype, and proteome-wide association assays to identify protein variants associated with severe COVID-19, providing clues for how these proteins may contribute to disease.

Linda Goodman, Co-Founder and CTO of Fauna Bio, compares animal and human genomes to identify new drug targets for heart disease, obesity, and more.

A group of researchers leveraged their location to tackle questions about the rare autoimmune disorder, Addison’s disease.

Biobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.